A study on the clinical equivalence and patient preference of fluticasone propionate 250 μg twice daily via the Diskus® /Accuhaler® inhaler or the Diskhaler® inhaler in adult asthmatic patients

Journal of Asthma

Volumn 35, Issue 4, 1998, Pages 337-345

  Pieters, W R ^a   Stallaert, R A L M ^b   Prins, J ^b   Greefhorst, A P M ^c   Bosman, H G ^d   Van Uffelen, R ^d   Schreurs, A J M ^e   Van Helmond, J L M ^f   Janssen, P G M ^g   Akveld, M L M ^g  

^a ELKERLIEK HOSPITAL   (Netherlands)

^b Westfriesgasthuis   (Netherlands)

^c Streekziekenhuis Midden Twente   (Netherlands)

^d Drechtsteden Ziekenhuis   (Netherlands)

^e ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

^f SINT FRANCISCUS GASTHUIS   (Netherlands)

^g GLAXOSMITHKLINE   (United States)

Author keywords

Inhaled corticosteroids; Multidose powder inhaler; Reversible airways obstruction

Indexed keywords

ANTIASTHMATIC AGENT; FLUTICASONE PROPIONATE; SALBUTAMOL;

ADULT; AGED; ARTICLE; ASTHMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INHALATIONAL DRUG ADMINISTRATION; INHALER; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PARALLEL DESIGN; PEAK EXPIRATORY FLOW; RANDOMIZED CONTROLLED TRIAL;

EID: 0031760908     PISSN: 02770903     EISSN: None     Source Type: Journal    
DOI: 10.3109/02770909809075666     Document Type: Article

References (25)

1. Phillipps GH: Structure-activity relationships of topically active steroids: the selection of fluticasone propionate. Respir Med 84(Suppl A):19-23 (1990).
2. De Blaquiere P, Christensen DB, Carter WB, Martin TR: Use and misuse of metered-dose inhalers by patients with chronic lung disease: A controlled, randomised trial of two instruction methods. Am Rev Respir Dis 140:910-916 (1989).
3. Keely D: Large volume plastic spacers in asthma: Should be used more. Br Med J 30(editorial): 598-599 (1992).
4. Cocchetto DM, Sykes RS, Spector S: Paradoxical bronchospasm after use of inhalation aerosols: A review of the literature. J Asthma 28(1):49-53 (1991).
5. Meades C, Churcher KM, Palmer JBD: An evaluation of the ease of handling the Diskhaler dry powder inhaler by asthmatic patients. Eur J Clin Res 2:43-50 (1992).
6. Drepaul BA, Payler DK, Qualtrough JE, Perry LJ, Bryony F, Reeve A, Charlton SC: Becotide or Becodisks? Clin Trials J 26(5):335-344 (1989).
7. O'Gorman PL, Dawson KP, Mogridge RN: Dry powder inhalation devices: consumer perceptions of two new devices. N Z Fam Physician Spring 3:182-18 (1990).
8. Van der Palen J, Klein JJ, Kerkhoff AHM, Van Herwaarden CLA: Evaluation of the effectiveness of four different inhalers in patients with chronic obstructive pulmonary disease. Thorax 50:1183-1187 (1995).
9. Sumby BS, Churcher KM, Smith IJ, Grant AC, Truman KG, Marriott RJ, Booth SJ: Dose reliability of the Serevent Diskhaler system. Pharm Technol Int June:20-27 (1993).
10. Spiro SG, Biddiscombe M, Marriott RJ, Short M, Taylor AJ: Inspiratory flow rates attained by asthmatic patients through a metered-dose inhaler and a Diskhaler inhaler. Br J Clin Res 3:115-116 (1992).
11. Prime D, Slater AL, Haywood PA, Smith IJ: Assessing dose delivery from the Flixotide Diskus inhaler - A multi-dose powder inhaler. Pharm Technol Eur March: 23-36 (1996).
12. Shaw RJ: Pharmacology of fluticasone propionate. Respir Med 88(Suppl A):5-8 (1994).
13. Harding SM: The human pharmacology of fluticasone propionate. Respir Med 84(Suppl A):25-29 (1990).
14. Geddes DM: Inhaled corticosteroids: benefits and risks. Thorax 47:404-407 (1992).
15. Fuller R, Johnson M, Bye A: Fluticasone propionate -an update on preclinical and clinical experience. Respir Med 89(Suppl A):3-18 (1995).
16. Gustafsson P, Tsanakas J, Gold M, Primhak R, Radford M, Gillies E: Comparison of the efficacy and safety of inhaled fluticasone propionate 200 μg/day with inhaled beclomethasone dipropionate 400 μg/day in mild and moderate asthma. Arch Dis Child 69:206-211 (1993).
17. -1) administered by pressurized inhaler. Respir Med 87:609-620 (1993).
18. Langdon CG, Capsey LJ: Fluticasone propionate and budesonide in adult asthmatics: a comparison using dry-powder inhaler devices. Br J Clin Res 5:85-99 (1994).
19. Connolly A: A comparison of fluticasone propionate 100 μg twice daily with budesonide 200 μg twice daily via their respective powder devices in the treatment of mild asthma. Eur J Clin Res 7:15-29 (1995).
20. Ayres JG, Bateman ED, Lundbäck B, Harris TAJ: High dose fluticasone propionate, 1 mg daily, versus fluticasone propionate, 2 mg daily, or budesonide, 1.6 mg daily, in patients with chronic asthma. Eur Respir J 8:579-586 (1995).
21. Hoekx J, Hollingworth K: A comparison of fluticasone propionate with budesonide in the treatment of children with asthma. Am J Respir Crit Care Med 151(4)(abstract):A150 (1995).
22. McNemar Q: Note on the sampling error of the difference between correlated proportions or percentages. Psychometrika 12(2):153-157 (1947).
23. Boulet LP, Cowie R, Johnston P, Krakovsky D, Mark S: Comparison of Diskus™ inhaler, a new multidose powder inhaler, with Diskhaler™ inhaler for the delivery of salmeterol to asthmatic patients. J Asthma 32(6):429-436 (1995).
24. Schlaeppi M, Edwards K, Fuller RW, Sharma R: Patients perception of the Diskus inhaler: A comparison with the Turbuhaler inhaler. Br J Clin Pract 50(1):14-19 (1996).
25. Holmes B: Which inhaler is best? J R Soc Med 82:64 (1989).